Delivery Order SPE2DX22D0010-SPE2D825FHC57

The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,077.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award utilized no set-aside designation and was competitively awarded, consistent with the company's established track record of federal medical procurement.

As a critical vendor for military and veteran healthcare systems, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies through its DLA contracts, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Medical Supply Chain's strategic approach involves establishing multiple regional contracts with different contractors, positioning AmerisourceBergen as a key provider supporting global military healthcare operations.